Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors
about
Noise filtering and nonparametric analysis of microarray data underscores discriminating markers of oral, prostate, lung, ovarian and breast cancerHigh-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancerIdentification of commonly dysregulated genes in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation.Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cellsThe role of the transcription factor SIM2 in prostate cancer.Loss of HOXC6 expression induces apoptosis in prostate cancer cells.Potential contribution of SIM2 and ETS2 functional polymorphisms in Down syndrome associated malignancies.Identification of residues in the N-terminal PAS domains important for dimerization of Arnt and AhR.Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomyQuantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arraysA novel role of myosin VI in human prostate cancerSim2 prevents entry into the myogenic program by repressing MyoD transcription during limb embryonic myogenesis.The bHLH/Per-Arnt-Sim transcription factor SIM2 regulates muscle transcript myomesin2 via a novel, non-canonical E-box sequence.Differential transcriptional regulation by mouse single-minded 2s.Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle.Apoptosis in Down's syndrome: lessons from studies of human and mouse models.Characterization of human variants in obesity-related SIM1 protein identifies a hot-spot for dimerization with the partner protein ARNT2.SIM2l attenuates resistance to hypoxia and tumor growth by transcriptional suppression of HIF1A in uterine cervical squamous cell carcinoma.Multiple roles of SIM2 in esophageal squamous cell carcinoma and its clinical implications.SIM2 maintains innate host defense of the small intestine.
P2860
Q24804521-37B9A8AB-ACE3-418B-9512-3C1A60D56644Q28480861-94144353-688E-4FDF-A680-942DA424E05FQ30938855-2CEB4CBB-2685-4ADB-B546-6F6AAF0B7C54Q33943930-9AE2396C-1AA2-4D62-AD9B-92C8B16CC2BFQ34103422-DE801F64-24A5-4D6D-9D47-ED6BE6B63BF3Q34382495-5F42E195-3D04-4ED2-A13C-7EDED2F54807Q34560086-FEAA49E6-A4B9-4DFA-8162-743F28C4D1D5Q34947089-9861F56B-71CB-4864-A1D9-96CEB5AA9C1CQ35070161-EFCE1535-1F0B-4CBF-A66E-ECF196436A30Q35103313-9EBD51F1-CEE5-455F-AA85-DF87EE5AB514Q35607414-34ABA6F1-2117-4009-BAD3-E5EED3CFE3EDQ35944746-300E1095-3FEC-418B-9581-A7DFD1B816D9Q38290987-109CD9CF-B891-440A-8743-A1A95ECDB680Q40315184-A7B32D45-8999-47A4-8845-C1AE23AAE0DDQ41073571-A351BAD7-9834-4909-A2B5-CD48FACD7920Q42396664-ADA75AB2-E5DD-433E-8E86-29CCC1A06206Q43723779-5A5E156E-FEDD-4CF5-BEC4-26365CE24938Q44180749-8C873959-6FC6-4905-B58F-5827B2AFD498Q47150172-C5C8E390-5F79-4B55-8CAA-4076C06C06C7Q50088769-A16F93F5-CA18-40D0-9783-1F3B6984E602Q50619594-E0FEA739-097F-46B3-BE58-514514E81074
P2860
Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumors
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Identification of Down's syndr ...... herapy target for solid tumors
@ast
Identification of Down's syndr ...... herapy target for solid tumors
@en
Identification of Down's syndr ...... herapy target for solid tumors
@nl
type
label
Identification of Down's syndr ...... herapy target for solid tumors
@ast
Identification of Down's syndr ...... herapy target for solid tumors
@en
Identification of Down's syndr ...... herapy target for solid tumors
@nl
prefLabel
Identification of Down's syndr ...... herapy target for solid tumors
@ast
Identification of Down's syndr ...... herapy target for solid tumors
@en
Identification of Down's syndr ...... herapy target for solid tumors
@nl
P2860
P356
P1476
Identification of Down's syndr ...... herapy target for solid tumors
@en
P2093
Matthew Tress
Maurice Phil DeYoung
P2860
P304
P356
10.1073/PNAS.0831000100
P407
P50
P577
2003-04-03T00:00:00Z